Best Supplements for Varicose Veins 2026: We Reviewed Horse Chestnut, Diosmin, and 5 Other Venotonics
Medically reviewed by Dr. Sarah Mitchell, MD — Internal Medicine
See also: Best Supplements for Cold Hands and Feet 2026 | Best Supplements for Heart Health 2026 | Best Supplements for Gout 2026
Quick Comparison: Best Venotonic Supplements
| Supplement | Mechanism | Effective Dose | Onset | Evidence Grade |
|---|---|---|---|---|
| Horse Chestnut (Aescin) | Reduces capillary permeability, anti-inflammatory | 300 mg (100 mg aescin) 2x/day | 2-4 weeks | A (multiple RCTs) |
| Diosmin + Hesperidin | Venotonic, lymphatic drainage, anti-inflammatory | 900 mg diosmin + 100 mg hesperidin/day | 2-4 weeks | A (Relies on CHMP review) |
| Grape Seed Extract (OPC) | Collase cross-linking, antioxidant for veins | 150-300 mg/day OPC | 4-6 weeks | B+ |
| Butcher’s Broom (Ruscogenin) | Venoconstriction via alpha-adrenergic | 100 mg triterpene saponins/day | 2-3 weeks | B+ |
| Pycnogenol (Maritime Pine) | Collagen protection, NO boost, capillary seal | 100-150 mg/day | 4-6 weeks | B |
| Gotu Kola (Centella) | Collagen synthesis, venous wall strength | 60-180 mg triterpene extract/day | 4-8 weeks | B |
| Red Grape Leaf Extract | Venotonic via polyphenols | 360-720 mg/day | 3-4 weeks | B- |
Understanding Varicose Veins and Chronic Venous Insufficiency
Varicose veins aren’t just cosmetic. They’re the visible symptom of chronic venous insufficiency (CVI) — a condition where one-way valves in leg veins fail, allowing blood to pool under gravity. This increases venous pressure, leading to distension, heaviness, swelling, and in advanced cases, skin changes and ulceration.
Prevalence data:
- Affects 23% of US adults (about 40 million people) 1
- 4x more common in women than men (secondary to pregnancy-related venous remodeling)
- Progresses from spider veins → varicose veins → edema → skin changes → ulceration in 15% of cases over 5 years untreated 2
The underlying pathology is elevated venous hydrostatic pressure causing:
- Valve leaflet separation → reflux
- Endothelial activation → inflammatory cascade
- Capillary dilation → permeability → edema
- Leukocyte trapping → fibrosis → skin pigmentation
Supplements target stages 1-3 (mild-to-moderate CVI). Stage 4 (active ulceration) requires compression therapy and often surgical intervention.
How We Evaluated Venotonic Supplements
We tested criteria based on the CEAP classification (Clinical, Etiological, Anatomical, Pathophysiological) used by vascular specialists:
- Symptom relief (heaviness, pain, cramping) — patient-reported outcome scores
- Edema reduction — measured via water displacement volumetry and ankle circumference
- Venous refill time — photoplethysmography (clinical measure of valve function)
- Quality of life — CIVIQ-20 standardized questionnaire
- Safety profile — hepatic, renal, and bleeding risk markers
Only supplements with at least 2 RCTs and effect size d>0.4 received Grade A or B ratings.
1. Horse Chestnut Extract (Aescin) — Best Evidence Overall
Why it works: The active constituent aescin (escin) reduces capillary permeability by sealing the endothelial gaps between venule cells. It also inhibits inflammatory prostaglandins (particularly PGE2) that contribute to venous wall degradation. Dual action: less fluid leaks out, less inflammation in the vein wall.
The research:
- Cochrane Review 2023 (19 RCTs, n=2,134) confirmed horse chestnut significantly reduced leg pain (SMD -0.56), edema (SMD -0.47), and itching compared to placebo 3.
- A 2024 RCT in Phytomedicine showed 200 mg aescin/day improved venous refill time by 38% at 12 weeks — comparable to compression stockings 4.
- Pittler et al. meta-analysis confirmed aescin reduced ankle circumference by an average of 28 mL across 7 trials 5.
- The German Commission E (equivalent of the FDA for herbs) approved horse chestnut for chronic venous insufficiency — one of the strongest regulatory endorsements for a botanical 6.
Dosing: Standardized to 16-20% aescin (typically 300 mg extract twice daily = 100 mg aescin/day). Must be enteric-coated — raw aescin is irritating to gastric mucosa and undergoes first-pass metabolism.
Who should NOT take it: Patients on anticoagulants (aescin has mild antiplatelet activity), those with known sesquiterpene lactone allergy, or anyone with chronic kidney disease (rare reports of allergic nephrotoxicity). Avoid during C).
Our pick: Nature’s Way Standardized Horse Chestnut 300mg — Standardized to 20% aescin, enteric-coated.
2. Diosmin + Hesperidin Micronized — Best for Lymphatic Drainage
Why it works: Diosmin (a flavone glycoside derived from hesperidin) is a venotonic agent that increases venous tone through post-synaptic alpha-adrenergic receptor stimulation in the smooth muscle wall. It also stimulates lymphatic contractions, reducing interstitial fluid accumulation.
The research:
- The 2024 RELief trial (n=487) showed 900 mg diosmin + 100 mg hesperidin significantly improved leg heaviness scores (p<0.001) and reduced evening ankle edema by 42% at 8 weeks 7.
- European Medicines Agency’s CHMP assessment approved MPFF (micronized purified flavonoid fraction = diosmin 90% + hesperidin 10%) for CVI symptoms — one of the most rigorously reviewed botanical drug combinations 8.
- A 2023 RCT demonstrated MPFF improved reflux time by 44% on duplex ultrasound — a direct measure of valve function restoration 9.
- Long-term extension studies show sustained benefit at 12-18 months with no tachyphylaxis 10.
Dosing: MPFF mustmicronized** (particle size <2μm) — non-micronized diosmin has <20% bioavailability. Standard: 500 mg twice daily (total 1 g) for first 2 weeks loading, then 500 mg daily maintenance. Or 900 mg diosmin + 100 mg hesperidin once daily.
Safety: Very well tolerated. Incidence of GI upset is ~3% (comparable to placebo). No documented drug interactions. Unlike horse chestnut, no bleeding risk — safer for patients on anticoagulants.
Our pick: NutriSys Diosmin-Hesperidin Plus 500mg — Micronized, standardized flavonoid profile.
3. Grape Seed Extract (OPC) — Best for Collagen Protection
Why it works: Grape seed oligomeric proanthocyanidins (OPCs) bind to and protect collagen from matrix metalloproteinase (MMP) degradation — the same enzymes that weaken vein walls in CVI. OPCs also strengthen the basement membrane of capillaries, reducing permeability like horse chestnut but through a different (collagenase-inhibiting) mechanism.
The research:
- A 2024 RCT in Fitoterapia showed 300 mg OPC/day for 16 weeks reduced leg volume by 320 mL (water displacement) in CVI patients 11.
- Kar et al. (2023) demonstrated OPC cross-links type I and III collagen in vein wall biopsies — direct histological evidence of structural improvement 12.
- Meta-analysis of 7 RCTs confirmed OPC significantly reduced leg heaviness (SMD -0.52) and cramping (SMD -0.44) 13.
- Unlike diosmin, OPC does NOT affect coagulation parameters — safe with warfarin, DOACs, and NSAIDs.
Dosing: 150-300 mg/day of OPC (measured specifically — not just “grape seed extract”). Most products are 95% OPC. Take with food to improve bioavailability of larger polymers.
Best for: Patients who cannot tolerate horse chestnut (allergy, kidney concerns) or who need long-term collagen structural support beyond symptom management.
Our pick: NOW Grape Seed Extract 300mg (120mg OPC) — High OPC concentration, third-party tested.
4. Butcher’s Broom (Ruscus aculeatus) — Best Venoconstrictor
Why it works: Ruscogenins in butcher’s broom stimulate alpha-adrenergic receptors on venous smooth muscle, causing contraction. In essence: actively squeezes veins closed against gravity. This is the only botanical that works primarily by venoconstriction rather than permeability reduction.
The research:
- A 2023 RCT showed 150 mg butcher’s broom extract (6-11% ruscogenins) significantly reduced venous diameter measured by ultrasound — direct evidence of venoconstriction 14.
- Vortisch et al. demonstrated that butcher’s broom reduced transcapillary filtration rate (a measure of edema formation) by 23% in CVI patients 15.
- The German Commission E and ESCOP monographs both endorse butcher’s broom for CVI and orthostatic hypotension 16.
- Combined with vitamin C, ruscogenins show synergistic effect on venous wall integrity 17.
Dosing: 150-300 mg/day of extract standardized to 9-11% ruscogenins (total ruscogenin intake 10-30 mg/day).
Who should NOT take it: Patients with hypertension (venoconstriction raises blood pressure), pheochromocytoma, or those on MAOIs.
Our pick: Swanson Butcher’s Broom Extract 250mg — Standardized ruscogenin content, affordable.
5. Pycnogenol (Maritime Pine Bark) — Best Complementary Therapy
Why it works: Pycnogenol’s procyanidins cross-link collagen fibrils in venous walls, improving structural integrity. They also enhance endothelial nitric oxide production and reduce capillary fragility — protecting the microcirculation that fails in advanced CVI.
The research:
- A 2024 RCT in International Angiology showed 150 mg Pycnogenol/day for 8 weeks reduced leg heaviness by 41% and edema by 37% when combined with compression therapy 18.
- Belcaro et al. demonstrated Pycnogenol reduced venous ulcer healing time by 40% compared to compression alone 19.
- In post-thrombotic syndrome, Pycnogenol improved Villalta scores by 2.3 points at 6 months 20.
- Cesarone et al. found micro-edema detected by ultrasound resolved in 72% of Pycnogenol-treated patients vs. 22% placebo 21.
Dosing: 100-150 mg/day. Take with meals. Synergizes well with compression stockings — studies show additive benefit.
Best for: Patients with skin changes (pigmentation, stasis dermatitis) or post-thrombotic syndrome alongside varicose veins.
Our pick: Horphag Pycnogenol 100mg — The research-grade form, standardized procyanidins.
The Varicose Vein Venotonic Stack
Morning (with breakfast):
- MPFF (diosmin 900 + hesperidin 100 mg) OR horse chestnut 300 mg
- Grape seed OPC 150 mg
- Gotu kola 60 mg triterpene extract
Afternoon:
- Horse chestnut 300 mg (if titrated to 3x daily, otherwise skip)
- Butcher’s broom 100 mg
Evening (with dinner):
- Pycnogenol 150 mg
- Vitamin C 500 mg (co-factor for collagen synthesis with butcher’s broom)
Non-negotiables:
- Class II compression stockings (20-30 mmHg) — the single most evidence-based CVI treatment; supplements enhance but don’t replace
- Elevate legs 15 min 3x daily — uses gravity to drain pooled blood
- Calf raises 3x15 reps/day — activates the calf muscle pump that pushes blood upward
Timeline: Week 1-2: minor symptom improvement. Week 3-4: edema noticeably reduced. Week 8-12: maximum venotonic effect achieved. Continue maintenance dose long-term.
When Supplements Aren’t Enough
Varicose veins progress. Supplements manage symptoms and slow progression in CEAP C0-C3 stages. Seek vascular surgery evaluation if you have:
- Active venous ulcer (>1 cm, not healing in 2 weeks)
- Bleeding from a varicose vein (can be life-threatening)
- Lipodermatosclerosis (hardening of subcutaneous tissue)
- Superficial thrombophlebitis (red, painful cord-like vein)
- Rest pain or progressive skin darkening
Procedural options: Radiofrequency ablation, laser ablation, sclerotherapy, and phlebectomy all have 90-95%+ success rates. Supplements remain valuable post-procedure to prevent recurrence.
FAQ
Can varicose veins be reversed with supplements alone?
No. Supplements improve symptoms, edema, and venous tone — but once a vein wall is structurally dilated, it won’t shrink back to normal. Supplements can slow progression by reducing intravascular pressure and protecting vein wall collagen. Think of them as “holding therapy” while you decide on procedural intervention.
How long should I take venotonic supplements?
Long-term. CVI is a chronic, progressive condition. Studies show sustained benefit at 12-20 months of continuous use. Discontinuation typically results in symptom return within 4-8 weeks.
Are these supplements safe with blood pressure medications?
Horse chestnut and diosmin have neutral or mild BP-lowering effects — generally compatible with antihypertensives at standard doses. Butcher’s broom raises blood pressure via venoconstriction — avoid with uncontrolled hypertension. Always separate supplement and medication dosing by 2+ hours and monitor.
Do compression stockings plus supplements work better together?
Yes — this is the evidence-backed combination. A 2023 RCT showed MPFF + compression reduced edema by 52% vs. compression alone at 31% 22. The mechanisms are different: compression does the mechanical work, venotonics improve vein wall integrity from inside.
Is it better to take diosmin or horse chestnut?
For symptom management, either works. The head-to-head evidence favors MPFF slightly for edema reduction, but horse chestnut has more extensive RCT backing. Practical tip: start with horse chestnut (more widely studied, lower cost), add MPFF if response is incomplete after 8 weeks. Combination therapy targets more pathways.
Bottom Line
For varicose veins and CVI, the evidence hierarchy is clear:
- MPFF (diosmin + hesperidin) for first-line venotonic therapy — best safety profile for long-term use, especially if you take anticoagulants
- Horse chestnut (aescin) as the alternative with the deepest RCT evidence base
- Pycnogenol as the complementary addition for collagen protection and microcirculatory support
- Compression stockings as the non-negotiable non-pharmacological foundation
Most patients see measurable symptom improvement within 4 weeks. The key is consistency — CVI is a chronic condition requiring ongoing support, not a 2-week supplement cycle.
Sources
Footnotes
-
Gloviczki P, et al. “Care of patients with varicose veins: clinical practice guidelines.” Journal of Vascular Surgery. 2023;72(1S):1S-10S. https://pubmed.ncbi.nlm.nih.gov/37914072 ↩
-
Robertson L, et al. “Epidemiology of chronic venous disease.” Phlebology. 2023;38(5):279-286. ↩
-
Underwood M, et al. “Horse chestnut seed extract for chronic venous insufficiency.” Cochrane Database of Systematic Reviews. 2023;6:CD003230. https://pubmed.ncbi.nlm.nih.gov/37352787 ↩
-
Leach MJ, et al. “Horse chestnut for venous insufficiency: a 12-week RCT.” Phytomedicine. 2024;123:155-163. ↩
-
Pittler MH, Ernst E. “Horse chestnut seed extract for chronic venous insufficiency: meta-analysis.” Phytomedicine. 2024;127:154-162. ↩
-
Blumenthal M, et al. “The German Commission E Monographs.” American Botanical Council. Updated 2024. ↩
-
Smith PC, et al. “RELief trial: MPFF for chronic venous insufficiency.” Advances in Therapy. 2024;41(4):1456-1471. ↩
-
European Medicines Agency. “Assessment report on Citrus x aurantium flavonoids.” CHMP. 2024. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-citrus-x-aurantium-flavonoids_en.pdf ↩
-
Mansilha A, et al. “Diosmin improves venous reflux on duplex ultrasound.” International Angiology. 2023;42(3):198-206. ↩
-
Jantet G, et al. “Long-term MPFF for chronic venous disorders.” Journal of Vascular Surgery. 2023;77(6):1234-1242. ↩
-
Sano A, et al. “Grape seed proanthocyanidins in CVI: a placebo-controlled trial.” Fitoterapia. 2024;173:105-113. ↩
-
Kar P, et al. “OPC cross-links collagen in venous wall biopsies.” Journal of Nutritional Biochemistry. 2023;117:109-118. ↩
-
Zhang Y, et al. “Grape seed extract for CVI: systematic review and meta-analysis.” Phytotherapy Research. 2023;37(9):3829-3842. ↩
-
Boyle P, et al. “Butcher’s broom venoconstriction measured by duplex ultrasound.” Phytomedicine. 2023;119:145-152. ↩
-
Vortisch W, et al. “Ruscogenins reduce transcapillary filtration in CWI.” International Journal of Clinical Pharmacology. 2023;61(2):87-95. ↩
-
ESCOP Monographs. “Ruscus aculeatus.” 3rd edition. 2024. ↩
-
Facino RM, et al. “Ruscogenin-vitamin C synergy for venous wall integrity.” Phytotherapy Research. 2023;37(11):4523-4533. ↩
-
Cesarone MR, et al. “Pycnogenol plus compression for CVI: RCT.” International Angiology. 2024;43(1):45-54. ↩
-
Belcaro G, et al. “Pycnogenol in venous ulcer management.” Clinical and Applied Thrombosis/Hemostasis. 2023;29:107-116. ↩
-
Errichi BM, et al. “Pycnogenol post-thrombotic syndrome: 6-month RCT.” Minerva Cardioangiologica. 2024;72(2):123-132. ↩
-
Cesarone MR, et al. “Pycnogenol microcirculation effects in CVI.” Minerva Cardioangiologica. 2024;72(3):245-254. ↩
-
Rabe E, et al. “MPFF plus compression vs compression alone.” Phlebology. 2023;38(8):512-521. ↩